Education
About Us
Working with TipRanks
Follow Us
BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
BTSG Stock Chart & Stats
$40.06
-$0.12(-0.69%)
At close: 4:00 PM EST
$40.06
-$0.12(-0.69%)
Day’s Range― - ―
52-Week Range$15.48 - $41.26
Previous CloseN/A
Volume351.53K
Average Volume (3M)4.71M
Market Cap
$7.22B
Enterprise Value$9.57B
Total Cash (Recent Filing)$140.34M
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)66.9
Beta1.06
Next Earnings
Feb 27, 2026EPS Estimate
0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.30
Shares Outstanding180,352,300
10 Day Avg. Volume4,742,774
30 Day Avg. Volume4,710,325
Financial Highlights & Ratios
PEG Ratio2.03
Price to Book (P/B)1.99
Price to Sales (P/S)0.29
P/FCF Ratio-57.52
Enterprise Value/Market Cap1.32
Enterprise Value/Revenue0.77
Enterprise Value/Gross Profit6.27
Enterprise Value/Ebitda21.46
Forecast
1Y Price Target
$45.63Price Target Upside13.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Generic Conversions And Margin ExpansionPlanned generic conversions and exclusive contract uptake enable a shift toward higher-margin volumes, supporting gross profit improvement and EBITDA expansion.
Limited Distribution Drug WinsOnco360's strong record of winning the majority of new oncology limited distribution drug launches supports continued top-line expansion as new oncology therapies reach the market.
Provider Services And Hospice ExpansionGrowth in Provider Services, including a nationwide palliative program rollout and targeted hospice share gains, broadens recurring revenue and strengthens the higher-margin service mix.
Bears Say
Infusion Cost ManagementWeak cost control in infusion operations has pressured margins despite revenue growth, and ongoing standardization efforts may take time to translate into sustained savings.
Reimbursement And Regulatory UncertaintyUncertainty around home health rate updates and the potential size of government recoupments could constrain deal activity and reduce visibility into future cash flows.
Revenue Headwinds From Divestitures And Policy RiskLower script volumes from prior divestitures and customer exits, combined with policy-driven drug pricing risks under IRA provisions, could dampen revenue momentum.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $15.48 and its highest was $41.26 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $7.22B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Feb 27, 2026 which is in 13 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Oct 28, 2025. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.248 by $0.052.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.35.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 180,352,300 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.3 in its last earnings report, beating expectations of $0.248. Following the earnings report the stock price went up 0.147%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$45.63 (13.90% Upside)
$45.63 (13.90% Upside)
Hedge Fund Trend
Decreased
By 747.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.14%
12-Months-Change
Fundamentals
Return on Equity
4.25%
Trailing 12-Months
Asset Growth
4.55%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance, with significant revenue and EBITDA growth across segments, especially in Pharmacy Solutions and Provider Services. The company successfully launched new therapies in Specialty Pharmacy and reported high patient satisfaction. However, challenges such as flat EBITDA margins, home health rate concerns, and a customer bankruptcy were noted. Overall, the positive aspects outweighed the negative, indicating a strong outlook.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$45.63
▲(13.90% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---